[go: up one dir, main page]

MX2022010391A - Metodo de preparacion de derivados de amina heterociclica. - Google Patents

Metodo de preparacion de derivados de amina heterociclica.

Info

Publication number
MX2022010391A
MX2022010391A MX2022010391A MX2022010391A MX2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A MX 2022010391 A MX2022010391 A MX 2022010391A
Authority
MX
Mexico
Prior art keywords
heterocyclicamine
derivatives
preparation
present
prepared
Prior art date
Application number
MX2022010391A
Other languages
English (en)
Inventor
Deok Ki Eom
Joon Seok Park
Qing Ri Li
Wol Young Kim
Hyae Jung Hyun
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020210025655A external-priority patent/KR102531088B1/ko
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Publication of MX2022010391A publication Critical patent/MX2022010391A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente divulgación se refiere a un método para preparar un derivado de amina heterocíclica, y el método de preparación según la presente divulgación tiene la ventaja de que puede prepararse un derivado de amina heterocíclica que tiene un contenido de impurezas reducido con un alto rendimiento.
MX2022010391A 2020-02-26 2021-02-26 Metodo de preparacion de derivados de amina heterociclica. MX2022010391A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20200023899 2020-02-26
KR1020210025655A KR102531088B1 (ko) 2020-02-26 2021-02-25 헤테로사이클릭아민 유도체의 제조 방법
PCT/KR2021/002440 WO2021172922A1 (ko) 2020-02-26 2021-02-26 헤테로사이클릭아민 유도체의 제조 방법

Publications (1)

Publication Number Publication Date
MX2022010391A true MX2022010391A (es) 2022-09-05

Family

ID=77490106

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010391A MX2022010391A (es) 2020-02-26 2021-02-26 Metodo de preparacion de derivados de amina heterociclica.

Country Status (9)

Country Link
US (1) US20230094404A1 (es)
EP (1) EP4112617A4 (es)
JP (1) JP7447291B2 (es)
CN (1) CN115151537B (es)
BR (1) BR112022016729A2 (es)
CO (1) CO2022011593A2 (es)
JO (1) JOP20220199A1 (es)
MX (1) MX2022010391A (es)
WO (1) WO2021172922A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102328682B1 (ko) 2018-08-27 2021-11-18 주식회사 대웅제약 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1347971E (pt) 2000-12-21 2006-06-30 Bristol Myers Squibb Co Inibidores tiazolilicos de tirosina-cinases da familia tec
US20060030016A1 (en) 2003-12-05 2006-02-09 Graham Cheetham Crystal structure of interleukin-2 tyrosine kinase (ITK) and binding pockets thereof
WO2005066335A1 (en) 2003-12-30 2005-07-21 Boehringer Ingelheim Pharmaceuticals, Inc. Crystal structure of the interleukin-2-inducible cell kinase (itk) kinase domain
NZ575650A (en) 2006-09-22 2011-10-28 Pharmacyclics Inc Pyrimidinopyrazole derivatives as inhibitors of Bruton's tyrosine kinase
WO2012035055A1 (en) * 2010-09-17 2012-03-22 Glaxo Group Limited Novel compounds
WO2014036016A1 (en) 2012-08-31 2014-03-06 Principia Biopharma Inc. Benzimidazole derivatives as itk inhibitors
CA2887465A1 (en) 2012-10-04 2014-04-10 University Of Utah Research Foundation Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
AR098136A1 (es) 2013-10-21 2016-05-04 Merck Patent Gmbh Compuestos de heteroarilo como inhibidores de btk y usos de los mismos
CN104628657A (zh) * 2013-11-06 2015-05-20 韩冰 一类治疗缺血性脑损伤的化合物及其用途
WO2016065138A1 (en) * 2014-10-22 2016-04-28 Dana-Farber Cancer Institute, Inc. Thiazolyl-containing compounds for treating proliferative diseases
KR102613433B1 (ko) * 2017-10-11 2023-12-13 주식회사 대웅제약 신규한 페닐피리딘 유도체 및 이를 포함하는 약학 조성물
KR102328682B1 (ko) * 2018-08-27 2021-11-18 주식회사 대웅제약 신규한 헤테로사이클릭아민 유도체 및 이를 포함하는 약학 조성물

Also Published As

Publication number Publication date
WO2021172922A1 (ko) 2021-09-02
JP2023515197A (ja) 2023-04-12
EP4112617A4 (en) 2024-03-13
JOP20220199A1 (ar) 2023-01-30
CO2022011593A2 (es) 2022-08-30
BR112022016729A2 (pt) 2022-10-11
CN115151537B (zh) 2024-09-06
CN115151537A (zh) 2022-10-04
JP7447291B2 (ja) 2024-03-11
US20230094404A1 (en) 2023-03-30
EP4112617A1 (en) 2023-01-04

Similar Documents

Publication Publication Date Title
PH12018500093A1 (en) Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
PH12019500493A1 (en) Solvate form of (r)-2-amino-3-phenylpropyl carbamate
MY203897A (en) Methods of producing omega-hydroxylated fatty acid derivatives
MY197904A (en) Method for producing substituted 5-fluoro-1h-pyrazolopyridines
PH12019502865A1 (en) Method for preparing intermediate of 4-methoxypyrrole derivative
MX395591B (es) Metodo para preparar derivado de benzofurano
PH12019502638A1 (en) Method for preparing intermediate of 4-methoxypyrrole derivative
MY178759A (en) Method for preparing trichlorosilane
MY164371A (en) Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase
MX2020006040A (es) Intermedios para derivados de piperidina opticamente activos y procedimientos de preparacion de los mismos.
NZ749715A (en) Leuconostoc mesenteroides cjlm119 strain producing reduced amount of gas, and kimchi production method using same
MX2022010391A (es) Metodo de preparacion de derivados de amina heterociclica.
ZA202401405B (en) Compositions and methods for anti-pacap antibodies
PH12022550095A1 (en) Novel method for preparing long-acting drug conjugate through preparation of intermediate
MX2018009847A (es) Metodo para preparar derivado de polietilenglicol-dialdehido.
IL279168B (en) A process for the preparation of eribulin
EA200870320A1 (ru) Способ получения г-ксф человека
WO2018196883A3 (zh) 一种16β-甲基甾族化合物的制备方法
WO2023108107A3 (en) Modified immune cells and methods of using the same
ZA202202129B (en) Process for the preparation of carboxylic acid derivatives of 3-bromo-4,5-dihydro-1h-pyrazoles
MX2022006383A (es) Procedimiento de purificacion de la hormona foliculo-estimulante.
WO2016079757A3 (en) NOVEL PROCESSES FOR THE PREPARATION OF SUBSTITUTED 5-HYDROXYMETHYL-OXAZOLIDINE-2-ONE
WO2016076573A3 (ko) 블로난세린의 제조방법 및 그를 위한 중간체
MX2025001080A (es) Proceso para la preparacion de 2-cloro-3-fluoro-4-alcoxi-anilinas y 2-fluoro-3-clorofenol
MX2024007500A (es) Procedimiento para la preparacion de derivados de (2r,3s)-2-(benzo[d]imidazolilpropil)piperidin-3-ol.